Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, also referred to
as drug-induced hypersensitivity syndrome, is a distinct, potentially life-threatening adverse …

Valproic acid is a widely-used first-generation antiepileptic drug, prescribed predominantly
in epilepsy and psychiatric disorders. VPA has good efficacy and pharmacoeconomic …

The Drug Reaction with Eosinophilia and Systemic Symptoms syndrome, also known as
Drug Induced Hypersensitivity Syndrome presents clinically as an extensive mucocutaneous …

About one third of patients with epilepsy do not benefit from medical treatment. For these
patients electroencephalographic (EEG) biofeedback is a viable alternative. EEG …

The multidrug transporter ABCG2 (BCRP/MXR/ABCP) can actively extrude a broad range of
endogenous and exogenous substrates across biological membranes. ABCG2 limits oral …

Although idiosyncratic adverse drug reactions are rare, they are still a major concern to
patient safety. Reactive metabolites are widely accepted as playing a pivotal role in the …

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, is also known
as drug induced hypersensitivity syndrome and by various other names. It is now recognised …

Several generations of antiepileptic drugs (AEDs) are available in the market for the
treatment of seizures, but these are amalgamated with acute to chronic side effects. The …

Clinically, erythema multiforme involves macular, papular or urticarial lesions, as well as the
classical iris or 'target lesions', distributed preferentially on the distal extremities. Lesions …

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a serious and
potentially fatal adverse effect to therapeutic medications. The incidence of this condition …